 |
PDBsum entry 1dec
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Blood coagulation
|
PDB id
|
|
|
|
1dec
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Science
264:1944-1947
(1994)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of the RGD protein decorsin: conserved motif and distinct function in leech proteins that affect blood clotting.
|
|
A.M.Krezel,
G.Wagner,
J.Seymour-Ulmer,
R.A.Lazarus.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The structure of the leech protein decorsin, a potent 39-residue antagonist of
glycoprotein IIb-IIIa and inhibitor of platelet aggregation, was determined by
nuclear magnetic resonance. In contrast to other disintegrins, the Arg-Gly-Asp
(RGD)-containing region of decorsin is well defined. The three-dimensional
structure of decorsin is similar to that of hirudin, an anticoagulant leech
protein that potently inhibits thrombin. Amino acid sequence comparisons suggest
that ornatin, another glycoprotein IIb-IIIa antagonist, and antistasin, a potent
Factor Xa inhibitor and anticoagulant found in leeches, share the same
structural motif. Although decorsin, hirudin, and antistasin all affect the
blood clotting process and appear similar in structure, their mechanisms of
action and epitopes important for binding to their respective targets are
distinct.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
G.S.Min,
I.N.Sarkar,
and
M.E.Siddall
(2010).
Salivary transcriptome of the North American medicinal leech, Macrobdella decora.
|
| |
J Parasitol,
96,
1211-1221.
|
 |
|
|
|
|
 |
J.H.Shiu,
C.Y.Chen,
L.S.Chang,
Y.C.Chen,
Y.C.Chen,
Y.H.Lo,
Y.C.Liu,
and
W.J.Chuang
(2004).
Solution structure of gamma-bungarotoxin: the functional significance of amino acid residues flanking the RGD motif in integrin binding.
|
| |
Proteins,
57,
839-849.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Micheletti,
V.De Filippis,
A.Maritan,
and
F.Seno
(2003).
Elucidation of the disulfide-folding pathway of hirudin by a topology-based approach.
|
| |
Proteins,
53,
720-730.
|
 |
|
|
|
|
 |
H.S.Park,
C.Kim,
and
Y.K.Kang
(2002).
Preferred conformations of RGDX tetrapeptides to inhibit the binding of fibrinogen to platelets.
|
| |
Biopolymers,
63,
298-313.
|
 |
|
|
|
|
 |
N.Assa-Munt,
X.Jia,
P.Laakkonen,
and
E.Ruoslahti
(2001).
Solution structures and integrin binding activities of an RGD peptide with two isomers.
|
| |
Biochemistry,
40,
2373-2378.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.M.Krezel,
J.S.Ulmer,
G.Wagner,
and
R.A.Lazarus
(2000).
Recombinant decorsin: dynamics of the RGD recognition site.
|
| |
Protein Sci,
9,
1428-1438.
|
 |
|
|
|
|
 |
B.M.Duggan,
H.J.Dyson,
and
P.E.Wright
(1999).
Inherent flexibility in a potent inhibitor of blood coagulation, recombinant nematode anticoagulant protein c2.
|
| |
Eur J Biochem,
265,
539-548.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.Kellenberger,
G.Mer,
C.Kellenberger,
G.Marguerie,
and
J.F.Lefèvre
(1999).
Solution structure of a conformationally constrained Arg-Gly-Asp-like motif inserted into the alpha/beta scaffold of leiurotoxin I.
|
| |
Eur J Biochem,
260,
810-817.
|
 |
|
|
|
|
 |
F.Vella,
J.F.Hernandez,
A.Molla,
M.R.Block,
and
G.J.Arlaud
(1999).
Grafting an RGD motif onto an epidermal growth factor-like module: chemical synthesis and functional characterization of the chimeric molecule.
|
| |
J Pept Res,
54,
415-426.
|
 |
|
|
|
|
 |
N.Verdaguer,
N.Sevilla,
M.L.Valero,
D.Stuart,
E.Brocchi,
D.Andreu,
E.Giralt,
E.Domingo,
M.G.Mateu,
and
I.Fita
(1998).
A similar pattern of interaction for different antibodies with a major antigenic site of foot-and-mouth disease virus: implications for intratypic antigenic variation.
|
| |
J Virol,
72,
739-748.
|
 |
|
|
|
|
 |
P.Polverino de Laureto,
E.Scaramella,
V.De Filippis,
O.Marin,
M.G.Doni,
and
A.Fontana
(1998).
Chemical synthesis and structural characterization of the RGD-protein decorsin: a potent inhibitor of platelet aggregation.
|
| |
Protein Sci,
7,
433-444.
|
 |
|
|
|
|
 |
D.J.Leahy
(1997).
Implications of atomic-resolution structures for cell adhesion.
|
| |
Annu Rev Cell Dev Biol,
13,
363-393.
|
 |
|
|
|
|
 |
E.Domingo,
and
J.J.Holland
(1997).
RNA virus mutations and fitness for survival.
|
| |
Annu Rev Microbiol,
51,
151-178.
|
 |
|
|
|
|
 |
J.T.Stubbs,
K.P.Mintz,
E.D.Eanes,
D.A.Torchia,
and
L.W.Fisher
(1997).
Characterization of native and recombinant bone sialoprotein: delineation of the mineral-binding and cell adhesion domains and structural analysis of the RGD domain.
|
| |
J Bone Miner Res,
12,
1210-1222.
|
 |
|
|
|
|
 |
M.R.Taylor,
J.R.Couto,
C.D.Scallan,
R.L.Ceriani,
and
J.A.Peterson
(1997).
Lactadherin (formerly BA46), a membrane-associated glycoprotein expressed in human milk and breast carcinomas, promotes Arg-Gly-Asp (RGD)-dependent cell adhesion.
|
| |
DNA Cell Biol,
16,
861-869.
|
 |
|
|
|
|
 |
M.S.Goligorsky,
E.Noiri,
H.Kessler,
and
V.Romanov
(1997).
Therapeutic potential of RGD peptides in acute renal injury.
|
| |
Kidney Int,
51,
1487-1492.
|
 |
|
|
|
|
 |
P.Lanza,
B.Felding-Habermann,
Z.M.Ruggeri,
M.Zanetti,
and
R.Billetta
(1997).
Selective interaction of a conformationally-constrained Arg-Gly-Asp (RGD) motif with the integrin receptor alphavbeta3 expressed on human tumor cells.
|
| |
Blood Cells Mol Dis,
23,
230-241.
|
 |
|
|
|
|
 |
P.R.Mittl,
S.Di Marco,
G.Fendrich,
G.Pohlig,
J.Heim,
C.Sommerhoff,
H.Fritz,
J.P.Priestle,
and
M.G.Grütter
(1997).
A new structural class of serine protease inhibitors revealed by the structure of the hirustasin-kallikrein complex.
|
| |
Structure,
5,
253-264.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.Lapatto,
U.Krengel,
H.A.Schreuder,
A.Arkema,
B.de Boer,
K.H.Kalk,
W.G.Hol,
P.D.Grootenhuis,
J.W.Mulders,
R.Dijkema,
H.J.Theunissen,
and
B.W.Dijkstra
(1997).
X-ray structure of antistasin at 1.9 A resolution and its modelled complex with blood coagulation factor Xa.
|
| |
EMBO J,
16,
5151-5161.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Eldor,
M.Orevi,
and
M.Rigbi
(1996).
The role of the leech in medical therapeutics.
|
| |
Blood Rev,
10,
201-209.
|
 |
|
|
|
|
 |
D.J.Leahy,
I.Aukhil,
and
H.P.Erickson
(1996).
2.0 A crystal structure of a four-domain segment of human fibronectin encompassing the RGD loop and synergy region.
|
| |
Cell,
84,
155-164.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.I.Jones,
T.Prevette,
A.Gockerman,
and
D.R.Clemmons
(1996).
Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor.
|
| |
Proc Natl Acad Sci U S A,
93,
2482-2487.
|
 |
|
|
|
|
 |
J.R.Couto,
M.R.Taylor,
S.G.Godwin,
R.L.Ceriani,
and
J.A.Peterson
(1996).
Cloning and sequence analysis of human breast epithelial antigen BA46 reveals an RGD cell adhesion sequence presented on an epidermal growth factor-like domain.
|
| |
DNA Cell Biol,
15,
281-286.
|
 |
|
|
|
|
 |
O.Lequin,
C.Albaret,
F.Bontems,
G.Spik,
and
J.Y.Lallemand
(1996).
Solution structure of bovine angiogenin by 1H nuclear magnetic resonance spectroscopy.
|
| |
Biochemistry,
35,
8870-8880.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.A.Lue,
E.Brandin,
E.P.Chan,
and
D.Branton
(1996).
Two independent domains of hDlg are sufficient for subcellular targeting: the PDZ1-2 conformational unit and an alternatively spliced domain.
|
| |
J Cell Biol,
135,
1125-1137.
|
 |
|
|
|
|
 |
A.Kidera
(1995).
Enhanced conformational sampling in Monte Carlo simulations of proteins: application to a constrained peptide.
|
| |
Proc Natl Acad Sci U S A,
92,
9886-9889.
|
 |
|
|
|
|
 |
B.Zhao,
L.R.Helms,
R.L.DesJarlais,
S.S.Abdel-Meguid,
and
R.Wetzel
(1995).
A paradigm for drug discovery using a conformation from the crystal structure of a presentation scaffold.
|
| |
Nat Struct Biol,
2,
1131-1137.
|
 |
|
|
|
|
 |
E.Domingo,
M.G.Mateu,
C.Escarmís,
E.Martínez-Salas,
D.Andreu,
E.Giralt,
N.Verdaguer,
and
I.Fita
(1995).
Molecular evolution of aphthoviruses.
|
| |
Virus Genes,
11,
197-207.
|
 |
|
|
|
|
 |
N.Verdaguer,
M.G.Mateu,
D.Andreu,
E.Giralt,
E.Domingo,
and
I.Fita
(1995).
Structure of the major antigenic loop of foot-and-mouth disease virus complexed with a neutralizing antibody: direct involvement of the Arg-Gly-Asp motif in the interaction.
|
| |
EMBO J,
14,
1690-1696.
|
 |
|
|
|
|
 |
P.Ascenzi,
G.Amiconi,
W.Bode,
M.Bolognesi,
M.Coletta,
and
E.Menegatti
(1995).
Proteinase inhibitors from the European medicinal leech Hirudo medicinalis: structural, functional and biomedical aspects.
|
| |
Mol Aspects Med,
16,
215-313.
|
 |
|
|
|
|
 |
P.Zhang,
S.Talluri,
H.Deng,
D.Branton,
and
G.Wagner
(1995).
Solution structure of the pleckstrin homology domain of Drosophila beta-spectrin.
|
| |
Structure,
3,
1185-1195.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.J.Sutcliffe,
M.Jaseja,
E.I.Hyde,
X.Lu,
and
J.A.Williams
(1994).
Three-dimensional structure of the RGD-containing neurotoxin homologue dendroaspin.
|
| |
Nat Struct Biol,
1,
802-807.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Jaseja,
X.Lu,
J.A.Williams,
M.J.Sutcliffe,
V.V.Kakkar,
R.A.Parslow,
and
E.I.Hyde
(1994).
1H-NMR assignments and secondary structure of dendroaspin, an RGD-containing glycoprotein IIb-IIIa (alpha IIb-beta 3) antagonist with a neurotoxin fold.
|
| |
Eur J Biochem,
226,
861-868.
|
 |
|
|
|
|
 |
M.T.Stubbs,
and
W.Bode
(1994).
Coagulation factors and their inhibitors.
|
| |
Curr Opin Struct Biol,
4,
823-832.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |